Back to search
FDAFDA · Food and drugs·Recall number D-0083-2021

DCL Active Mattifying Cleanser (Salicylic Acid 2%), 125mL/4.2 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 357486509627

Published November 25, 2020 · Recall initiated: October 9, 2020

Summary

FDA records drug Class II recall D-0083-2021, published November 25, 2020 and initiated October 9, 2020. Recalling firm: Milbar Laboratories, Inc.; Status: Terminated; Reported quantity: 4,878 tubes; Lot: Lot # FW937, Exp. Date Jun-22. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

GMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Milbar Laboratories, Inc.
Distributor
Product was distributed throughout the United States, including Puerto Rico and internationally.
UPC
357486509627
Lot
Lot # FW937, Exp. Date Jun-22
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DCL Active Mattifying Cleanser (Salicylic Acid 2%), 125mL/4.2 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 357486509627 recalled?

Yes. FDA published recall D-0083-2021 on November 25, 2020. Reported hazard: GMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 357486509627.